Cullen Investment Group, Ltd. Novartis Ag Transaction History
Cullen Investment Group, Ltd.
- $678 Billion
- Q4 2024
A detailed history of Cullen Investment Group, Ltd. transactions in Novartis Ag stock. As of the latest transaction made, Cullen Investment Group, Ltd. holds 5,611 shares of NVS stock, worth $612,216. This represents 0.08% of its overall portfolio holdings.
Number of Shares
5,611
Previous 5,855
4.17%
Holding current value
$612,216
Previous $673 Million
18.92%
% of portfolio
0.08%
Previous 0.1%
Shares
4 transactions
Others Institutions Holding NVS
# of Institutions
1,479Shares Held
134MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.33 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.2 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$893 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$749 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$609 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $235B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...